A Baltimore company will be at the forefront of producing a potential coronavirus vaccine.
Once a COVID-19 vaccine is ready for mass production, the company is going to be making hundreds of millions of them.
"We'll be providing the drug substance manufacturing which is essentially the vaccine itself," says Syed Husain, senior vice president of Emergent BioSolutions.
All of that work will happen at Emergent BioSolutions, which is located in front of Johns Hopkins Bayview.